Eutilex Co.
Latest round
- Series A
Last raised
- Dec 2016
Total raised
- $1.8M
Investors
- 4
About Eutilex Co.
, Ltd., Ltd. specializes in immunotherapy solutions. The company is headquartered in Seoul, South Korea.Eutilex specializes in the development of breakthrough immunotherapeutics, focusing primarily on antibody therapies and T cell therapies, including CAR-T cell therapies. These innovative treatment solutions aim to address various types of incurable diseases, particularly those that are resistant to traditional therapies.9. The company aims to expand into European and North American markets by 2025, positioning itself to meet the growing demand for advanced cancer treatment options.
Who invested in Eutilex Co.
4 investors across 1 round
See all investors in Eutilex Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 9, 2016
Amount
$1.8M
Investors
Questions about Eutilex Co.
Who invested in Eutilex Co.?
Eutilex Co. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eutilex Co. raised?
Eutilex Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eutilex Co. last raise money?
Eutilex Co.'s most recent round on record is a Series A, in Dec 2016.
What does Eutilex Co. do?
Eutilex Co. is a pharmaceuticals company.
Where is Eutilex Co. headquartered?
Eutilex Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Eutilex Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Eutilex Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Eutilex Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.